A lymphoma specialist who survived her own tumor surgery helps patients navigate the daunting decisions to be made.
10 天on MSN
Based on the No. 1 podcast of the same name, “Scamanda” tells the story of Amanda Riley, whose tragic cancer tale captivated ...
Dilan Patel, a nine-year cancer survivor says he has one drink daily to help prevent the disease. While there is no miracle ...
The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...
12 天on MSN
Dilan Patel, a women's health coach, has shared his story online of unexpectedly being diagnosed with cancer at 25-years-old ...
7 天
News Medical on MSNThe CAR T Veteran: A Journey of Resilience, Remission, and AdvocacyLaurie Adami's experience with CAR T-cell therapy highlights its potential in treating Non-Hodgkin Lymphoma, emphasizing the ...
A young woman who was diagnosed with cancer in December 2023 has encouraged people in the same position to “think of the ...
Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.
Extranodal non-Hodgkin lymphoma (NHL) makes up over one-third of NHL cases, yet remains understudied and in need of deeper ...
Rahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of waveLINE-010, a pivotal ...
MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated ...
On World Cancer Day, Mamta Mohandas, Yuvraj Singh, Lisa Ray, and others inspire with their cancer survival stories.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果